$NLTX Neoleukin Therapeutics, Inc. Insider Trading
Get free email notifications about insider trading in Neoleukin Therapeutics, Inc..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of insider trading in Neoleukin Therapeutics, Inc.. Insider overview, share value development, latest insider transactions and email notifications about new events in Neoleukin Therapeutics, Inc. for free.
CIK Number: 0001404644
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Trading Symbol: NLTX
Company Address: SUITE 360 - 1616 EASTLAKE AVE EAST SEATTLE 98102
Phone number: 604-629-9223
Former name: AQUINOX PHARMACEUTICALS (USA) INC, date of change: 2007-06-26
Former name: AQUINOX PHARMACEUTICALS, INC, date of change: 2014-01-28
Market Capitalization: $451.60M
Prev close: $18.81
Average Daily Volume: 169,561
Days Low: $18.43
Year Low: $6.01
Year High: $19.90
Neoleukin Therapeutics, Inc. Latest Insider Transactions
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Jun 09 2021 | NLTX | Neoleukin Therapeu ... | Walkey Carl | Senior Vice Preside ... | Sell | S | 11.00 | 600 | 6,600 | 1,353,739 | 1.4 M to 1.4 M (-0.04 %) |
May 13 2021 | NLTX | Neoleukin Therapeu ... | Williams Lewis T | Director | Option Exercise | A | 11.40 | 25,000 | 285,000 | 25,000 | |
May 13 2021 | NLTX | Neoleukin Therapeu ... | SIMPSON TODD E | Director | Option Exercise | A | 11.40 | 25,000 | 285,000 | 25,000 | |
May 13 2021 | NLTX | Neoleukin Therapeu ... | Noonberg Sarah B. | Director | Option Exercise | A | 11.40 | 25,000 | 285,000 | 25,000 | |
May 13 2021 | NLTX | Neoleukin Therapeu ... | Lavelle Erin M. | Director | Option Exercise | A | 11.40 | 25,000 | 285,000 | 25,000 | |
May 13 2021 | NLTX | Neoleukin Therapeu ... | Babler Martin | Director | Option Exercise | A | 11.40 | 25,000 | 285,000 | 25,000 | |
May 13 2021 | NLTX | Neoleukin Therapeu ... | BAKER BROS. ADVISORS LP | Director | Option Exercise | A | 11.40 | 25,000 | 285,000 | 25,000 | |
May 12 2021 | NLTX | Neoleukin Therapeu ... | Walkey Carl | Senior Vice Preside ... | Sell | S | 11.09 | 1,200 | 13,308 | 1,354,762 | 1.4 M to 1.4 M (-0.09 %) |
May 06 2021 | NLTX | Neoleukin Therapeu ... | Walkey Carl | Senior Vice Preside ... | Sell | S | 11.30 | 1,200 | 13,560 | 1,355,962 | 1.4 M to 1.4 M (-0.09 %) |
Apr 30 2021 | NLTX | Neoleukin Therapeu ... | Walkey Carl | Senior Vice Preside ... | Sell | S | 12.58 | 2,400 | 30,192 | 1,357,162 | 1.4 M to 1.4 M (-0.18 %) |
Apr 27 2021 | NLTX | Neoleukin Therapeu ... | Walkey Carl | Senior Vice Preside ... | Sell | S | 13.00 | 600 | 7,800 | 1,359,562 | 1.4 M to 1.4 M (-0.04 %) |
Apr 22 2021 | NLTX | Neoleukin Therapeu ... | Walkey Carl | Senior Vice Preside ... | Sell | S | 11.98 | 1,800 | 21,564 | 1,360,162 | 1.4 M to 1.4 M (-0.13 %) |
Apr 16 2021 | NLTX | Neoleukin Therapeu ... | Walkey Carl | Senior Vice Preside ... | Sell | S | 12.22 | 1,800 | 21,996 | 1,361,962 | 1.4 M to 1.4 M (-0.13 %) |
Apr 08 2021 | NLTX | Neoleukin Therapeu ... | Walkey Carl | Senior Vice Preside ... | Sell | S | 12.02 | 1,800 | 21,636 | 1,363,762 | 1.4 M to 1.4 M (-0.13 %) |
Apr 06 2021 | NLTX | Neoleukin Therapeu ... | Walkey Carl | Senior Vice Preside ... | Sell | S | 13.00 | 600 | 7,800 | 1,365,562 | 1.4 M to 1.4 M (-0.04 %) |